[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 116, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1635958, "exercisedValue": 0, "unexercisedValue": 3699450}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 943077, "exercisedValue": 0, "unexercisedValue": 1056212}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 45, "title": "General Counsel & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 816300, "exercisedValue": 0, "unexercisedValue": 860184}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 47.7, "open": 47.59, "dayLow": 46.76, "dayHigh": 47.76, "regularMarketPreviousClose": 47.7, "regularMarketOpen": 47.59, "regularMarketDayLow": 46.76, "regularMarketDayHigh": 47.76, "payoutRatio": 0.0, "beta": 2.633, "forwardPE": -4.315307, "volume": 292269, "regularMarketVolume": 292269, "averageVolume": 406040, "averageVolume10days": 642140, "averageDailyVolume10Day": 642140, "bid": 34.22, "ask": 60.54, "bidSize": 1, "askSize": 2, "marketCap": 990836288, "fiftyTwoWeekLow": 26.7, "fiftyTwoWeekHigh": 91.83, "priceToSalesTrailing12Months": 127.60287, "fiftyDayAverage": 48.6032, "twoHundredDayAverage": 55.681675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 690315392, "profitMargins": 0.0, "floatShares": 15924080, "sharesOutstanding": 21045800, "sharesShort": 2120688, "sharesShortPriorMonth": 1781578, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.1008, "heldPercentInsiders": 0.00156, "heldPercentInstitutions": 1.18665, "shortRatio": 4.92, "shortPercentOfFloat": 0.1009, "impliedSharesOutstanding": 21045800, "bookValue": 19.212, "priceToBook": 2.4505517, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -251012000, "trailingEps": -12.4, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 88.901, "enterpriseToEbitda": -2.544, "52WeekChange": -0.091821015, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 47.08, "targetHighPrice": 270.0, "targetLowPrice": 33.0, "targetMeanPrice": 103.33333, "targetMedianPrice": 82.5, "recommendationMean": 1.58333, "recommendationKey": "buy", "numberOfAnalystOpinions": 12, "totalCash": 301275008, "totalCashPerShare": 14.315, "ebitda": -271353984, "totalDebt": 755000, "quickRatio": 6.198, "currentRatio": 6.307, "totalRevenue": 7765000, "debtToEquity": 0.187, "revenuePerShare": 0.381, "returnOnAssets": -0.37978, "returnOnEquity": -0.60975, "grossProfits": -214216000, "freeCashflow": -104045248, "operatingCashflow": -191308000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -34.97566, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "regularMarketChangePercent": -1.29979, "regularMarketPrice": 47.08, "epsTrailingTwelveMonths": -12.4, "epsForward": -10.91, "epsCurrentYear": -13.36616, "priceEpsCurrentYear": -3.5223281, "fiftyDayAverageChange": -1.5231972, "fiftyDayAverageChangePercent": -0.031339444, "twoHundredDayAverageChange": -8.601673, "twoHundredDayAverageChangePercent": -0.15447943, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "postMarketChangePercent": 0.0, "postMarketPrice": 47.08, "postMarketChange": 0.0, "regularMarketChange": -0.619999, "regularMarketDayRange": "46.76 - 47.76", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 406040, "fiftyTwoWeekLowChange": 20.380001, "fiftyTwoWeekLowChangePercent": 0.7632959, "fiftyTwoWeekRange": "26.7 - 91.83", "fiftyTwoWeekHighChange": -44.75, "fiftyTwoWeekHighChangePercent": -0.4873135, "fiftyTwoWeekChangePercent": -9.182101, "earningsTimestamp": 1754310600, "earningsTimestampStart": 1754310600, "earningsTimestampEnd": 1754310600, "earningsCallTimestampStart": 1754310600, "earningsCallTimestampEnd": 1754310600, "isEarningsDateEstimate": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755290074, "regularMarketTime": 1755288000, "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]